Your browser doesn't support javascript.
loading
Revisiting beta 2 glycoprotein I, the major autoantigen in the antiphospholipid syndrome
IJI-Iranian Journal of Immunology. 2012; 9 (2): 75-85
in English | IMEMR | ID: emr-152164
ABSTRACT
Beta 2 glycoprotein I [beta2GPI] is a single chain 50 kDa highly glycosylated glycoprotein at an approximate concentration of 4 micro M in cells. The abundance of this protein in plasma and its high state of preservation indicate the important role of this protein in mammalian. In addition, beta2GPI has a particular structure in the fifth domain, and is categorized as the major antigen recognized by autoantibodies present in antiphospholipid syndrome. Beta 2 glycoprotein I has been usually studied in the context of antiphospholipid antibody production. Complexes of beta2GPI/anti-beta2GPI antibodies have been examined in different coagulation and cell activation pathways. However, the function of beta2GPI, independent from the antibodies, has not been clearly determined. In this paper different features of beta2GPI including its structure, plasma concentration and its proposed in vitro and in vivo functions in clot formation and fibrinolysis along with anti-beta2GPI antibodies [Abs] are discussed. Their inhibitory or promotive effects are delineated in each facet
Search on Google
Index: IMEMR (Eastern Mediterranean) Language: English Journal: Iran. J. Immunol. Year: 2012

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Index: IMEMR (Eastern Mediterranean) Language: English Journal: Iran. J. Immunol. Year: 2012